Pfizer Inc (NYSE:PFE) Stock News, Headlines & Updates
Pfizer Inc Stock News from GuruFocus
- 1
Jun 03, 2024
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Business Wire • 10:00am
Jun 01, 2024
Pfizer's ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/?Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Business Wire • 8:00am
May 31, 2024
Pfizer's LORBRENA® CROWN Study Shows Majority of Patients with ALK-Positive Advanced Lung Cancer Living Beyond Five Years Without Disease Progression
Business Wire • 8:00am
May 10, 2024
Decoding Pfizer Inc (PFE): A Strategic SWOT Insight
GuruFocus Research • 11:02pm
May 08, 2024
Pfizer Inc's Dividend Analysis
GuruFocus Research • 5:01am
May 07, 2024
Market Today: Pfizer Pauses Gene Therapy Trial After Patient Death
GuruFocus Research • 4:32pm
May 06, 2024
Pfizer Announces New Chief Strategy and Innovation Officer
Business Wire • 6:00am
May 02, 2024
Pfizer Inc (PFE) Q1 2024 Earnings Call Transcript Highlights: Navigating Post-COVID Challenges and Advancing Oncology Portfolio
GuruFocus Research • 1:17am
Q1 2024 Pfizer Inc Earnings Call Transcript
GuruFocus Research • 11:15pm
May 01, 2024
Pfizer Inc (PFE) Q1 2024 Earnings: Adjusted EPS Surpasses Expectations Amidst Revenue Decline
GuruFocus Research • 7:32am
Apr 29, 2024
FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer
Business Wire • 6:00pm
Pfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual Meeting
Business Wire • 6:00am
Apr 26, 2024
U.S. FDA Approves Pfizer's BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B
Business Wire • 6:00am
Apr 24, 2024
Pfizer Declares Second-Quarter 2024 Dividend
Business Wire • 4:00pm
Apr 22, 2024
European Commission Approves Pfizer's EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options
Business Wire • 8:00am
Apr 11, 2024
Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25
Business Wire • 10:00am
Apr 09, 2024
Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease
Business Wire • 6:00am
Mar 20, 2024
Pfizer Invites Public to View and Listen to Webcast of May 1 Conference Call with Analysts
Business Wire • 10:00am
Mar 16, 2024
Pfizer Is Too Cheap to Ignore
Dilantha De Silva • 2:49am
Mar 13, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news